EULAR 2023 Insights
EULAR 2023 Insights: Effect of Denosumab on Structure Modification in Erosive Hand OA: Results from 48-Week Phase 2 Study
By
EULAR 2023 Insights
FEATURING
Ruth Wittoek
By
EULAR 2023 Insights
FEATURING
Ruth Wittoek
Login to view comments.
Click here to Login
